PERIOVANCE
Live / Applied — First extension granted (statement of use) (as of 11 Aug 2025)
What this means for you
Not registered yet, but its 24 Sept 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98194634
- Mark type
- Stylized text
- Filed
- 24 Sept 2023
- Published for opposition
- 25 Jun 2024
- Attorney of record
- Michael A. Geller
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical products and preparations for the treatment of periodontitis, gingivitis, and pre-gingivitis; pharmaceutical products and preparations for the treatment of oral and dental diseases, conditions, and disorders; pharmaceutical products and preparations for oral and dental health care; all of the foregoing excluding products for immunotherapy treatments and products for the treatment of cancer, oncological and autoimmune diseases
Owner
- Periovance Inc., Pittsburgh, PA, US
- Periovance Inc., Pittsburgh, PA, US
Prosecution history
- 17 Nov 2025 — TEAS STATEMENT OF USE RECEIVED
- 12 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Aug 2025 — SOU EXTENSION 1 GRANTED
- 11 Aug 2025 — SOU EXTENSION 1 FILED
- 11 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Jan 2025 — POST PUBLICATION AMENDMENT - ENTERED
- 27 Jan 2025 — ASSIGNED TO PETITION STAFF
- 02 Jan 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 18 Dec 2024 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 23 Jul 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 25 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Jun 2024 — PUBLISHED FOR OPPOSITION
- 05 Jun 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 May 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER